(1R,2R)-(-)-1,2-Cyclohexanedicarboxylic Acid | CAS:46022-05-3

We serve (1R,2R)-(-)-1,2-Cyclohexanedicarboxylic Acid CAS:46022-05-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
(1R,2R)-(-)-1,2-Cyclohexanedicarboxylic Acid

Chemical Name:(1R,2R)-(-)-1,2-Cyclohexanedicarboxylic Acid
CAS.NO:46022-05-3
Synonyms:(1R,2R)-1,2-Cyclohexanedicarboxylic Acid
(1R,2R)-Cyclohexane-1,2-dicarboxylic acid
Molecular Formula:C8H12O4
Molecular Weight:172.17800
 
Physical and Chemical Properties:
Density:1.315
Melting point:184ºC
Boiling point:384.075ºC
Flash point:200.254ºC
 
Specification:
Appearance:Off-white solid
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediates of Lurasidone
 
Note:The product under valid patents will not be offered to the countries covered by patents.



Contact us for information like (1R,2R)-(-)-1,2-Cyclohexanedicarboxylic Acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(1R,2R)-Cyclohexane-1,2-dicarboxylic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(1R,2R)-1,2-Cyclohexanedicarboxylic Acid Use and application,(1R,2R)-1,2-Cyclohexanedicarboxylic Acid technical grade,usp/ep/jp grade.


Related News: The new restrictions on foreign nationals begin on February 3, Prime Minister Jacinda Ardern announced in a press release Sunday.2-Fluorobenzyl bromide manufacturer “Administrative Measures for the Joint Review, Review and Approval of Raw Materials, Medicinal Auxiliaries and Pharmaceutical Packaging Materials and Pharmaceutical Preparations” (Consultation Draft) issued by the State Food and Drug Administration in December 2017. Supervision departments no longer accept applications for registration of APIs, pharmaceutical excipients, and packaging materials.5-Fluoro-2-methylphenol supplier AstraZeneca Plc said on Monday that its cancer drug met the main goal of delaying the progression of a form of lung cancer.-Butylbenzofuran vendor AstraZeneca Plc said on Monday that its cancer drug met the main goal of delaying the progression of a form of lung cancer.Others — somewhat more cynically — wondered if this was a concerted effort to promote certain herbal products to boost their makers’ share prices ahead of the Chinese stock market’s re-opening Monday.